JLE

European Journal of Dermatology

MENU

Bisphosphonate-related osteonecrosis of the rib Volume 29, numéro 4, July-August 2019

Illustrations


  • Figure 1
Auteurs
Department of Dermatology,
Graduate School of Medical Sciences,
Kyushu University
3-1-1, Maidashi,
Higashi-ku, Fukuoka 812-8582,
Japan

Bisphosphonates are compounds widely used in the treatment of osteoporosis and other bone-absorbing conditions. Despite the appreciable benefits of bisphosphonates, bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a significant and unpredictable complication in a subset of patients who receive these drugs [1]. The accurate incidence, clinical background and pathogenesis of BRONJ remain unclear. Therefore, appropriate approaches for prevention and treatment have not been established. To [...]